November 19, 2026

MegaRobo Raises Nearly $200 Million: How AI-Powered Robotics Is Transforming the Future of Scientific Research


MegaRobo Raises Nearly $200 Million: How AI-Powered Robotics Is Transforming the Future of Scientific Research

Hookline: What if artificial intelligence could do more than analyse information and generate predictions? What if it could independently design experiments, operate laboratory equipment and accelerate scientific discoveries? With nearly $200 million in fresh funding, MegaRobo is bringing this vision closer to reality by connecting AI with the physical world.

Artificial intelligence is rapidly transforming industries, from healthcare and finance to manufacturing and biotechnology. While most AI applications focus on analysing information, generating content and automating digital processes, a new generation of technology companies is taking AI beyond computer screens and into the physical world.

One company leading this emerging transformation is MegaRobo, a China-based technology company developing AI-powered laboratory automation, robotics and intelligent manufacturing solutions.

In November 2026, MegaRobo announced that it had secured nearly $200 million in a new funding round, attracting significant attention from international investors. The investment highlights growing confidence in AI-powered scientific research and the potential of intelligent automation to transform pharmaceutical development, biotechnology and advanced manufacturing.

MegaRobo Secures Nearly $200 Million: Who Are the Investors?

On November 18, 2026, MegaRobo announced its latest financing round of nearly $200 million. The funding includes participation from the Oman Investment Authority (OIA), the sovereign wealth fund of the Sultanate of Oman.

Existing investors, including Asia Investment Capital, Granite Asia and Sinovation Ventures, continued their support, while CMB International joined as a new participant.

The company plans to utilise the fresh capital to strengthen its core technology, accelerate the global expansion of its AI for Science business and develop infrastructure that enables artificial intelligence to operate in increasingly complex physical environments.

With this latest investment, MegaRobo’s cumulative fundraising has reached approximately $600 million across multiple financing rounds.

One of its major previous funding milestones was a nearly $300 million Series C round co-led by Goldman Sachs Alternatives, Asia Investment Capital and Granite Asia, with participation from Pavilion Capital.

The latest funding demonstrates increasing investor interest in companies combining artificial intelligence, robotics, scientific research and industrial automation.

What Does MegaRobo Do?

Founded in 2016, MegaRobo develops intelligent automation technologies that connect artificial intelligence with physical equipment and scientific instruments.

The company primarily focuses on two areas: scientific intelligence and industrial intelligence.

Its scientific intelligence business focuses on automating laboratory workflows, pharmaceutical research and biotechnology experiments. Its industrial intelligence business provides automation and AI-based solutions for manufacturing industries, including semiconductors, optical interconnects and display production.

One of its important technology initiatives is AI for Science (AI4S), which uses artificial intelligence, machine learning and automated experimentation to improve scientific research.

Traditionally, researchers spend considerable time conducting manual experiments, analysing results and repeating tests. MegaRobo aims to simplify these processes by connecting intelligent software with robotic systems and automated laboratory equipment.

This approach can help research organisations improve operational efficiency, generate structured experimental data and accelerate research workflows.

According to the company’s November announcement, MegaRobo has delivered products and technologies to more than 500 customers, including pharmaceutical companies, biotechnology businesses and research institutions.

How AI and Robotics Are Transforming Scientific Research

MegaRobo’s technology focuses on creating an integrated ecosystem where artificial intelligence can interact directly with laboratory equipment.

Its proprietary One Intelligence Stack connects AI models, agents, data, workflows, software, scientific instruments and robotics.

The system follows a continuous process:

  • Think: AI analyses scientific information and identifies research possibilities.
  • Design: Intelligent systems help researchers develop experimental plans.
  • Execute: Automated laboratory equipment and robotic systems perform experiments.
  • Observe: The platform collects experimental results and generates structured data.
  • Learn: AI analyses the outcomes to improve future experiments.

Another important offering is Megalaxy Lab, an automated experimentation platform that allows researchers and AI agents to configure experiments, coordinate laboratory equipment and receive structured results.

This technology aims to reduce repetitive manual work and create a continuous feedback loop between AI predictions and real-world experimental results.

Recent Developments: MegaRobo Launches Poreva Open

One of MegaRobo’s most significant recent developments came on October 19, 2026, when the company launched Poreva Open, a global AI protein design challenge.

The initiative was developed with industry partners, including Tencent Cloud and Twist Bioscience, to bring together researchers, biotechnology companies and AI developers from around the world.

The competition focuses on testing AI-generated protein designs through real laboratory experiments rather than relying entirely on computer-generated predictions.

Under the initiative, more than 10,000 protein designs are expected to undergo standardised wet-lab validation through MegaRobo’s Megalaxy Lab.

The competition includes challenges involving EGFR, TNF-alpha and GLP-1R, with additional challenges planned.

Poreva Open also offers $250,000 in cash prizes and $150,000 in laboratory validation credits. Selected participants may have opportunities to receive potential investment of up to $1.5 million.

This initiative is important because it connects AI-driven protein design with actual experimental evidence, helping researchers evaluate the practical performance of their models.

Who Founded MegaRobo?

MegaRobo was founded in 2016 by Daniel Huang (Huang Yuqing), who serves as the company’s CEO.

His vision is to connect artificial intelligence with real-world scientific and industrial processes.

Under his leadership, MegaRobo has developed an integrated technology ecosystem combining robotics, AI, software and hardware.

The company’s long-term ambition is to build reusable intelligence infrastructure that enables AI systems to interact with physical environments, conduct experiments and generate new scientific knowledge.

What Does the Future Hold for MegaRobo?

MegaRobo’s latest funding comes at a time when global industries are increasingly exploring the possibilities of AI-powered automation.

Pharmaceutical companies could benefit from faster drug discovery workflows, biotechnology businesses could improve experimental processes, and manufacturers could use intelligent automation to improve production quality and efficiency.

However, expanding these technologies globally will require continued research and development, reliable experimental results, integration with existing infrastructure and strong customer adoption.

MegaRobo also faces competition from established laboratory automation and industrial technology providers. Its ability to demonstrate measurable customer value and build scalable business operations will be important for its future success.

With approximately $600 million raised to date, growing customer adoption and international investor participation, MegaRobo is positioning itself as an emerging player in the AI-powered scientific research and automation market.

Conclusion

MegaRobo’s nearly $200 million funding round represents more than another major startup investment. It reflects a broader transformation in the artificial intelligence industry, where innovation is moving beyond digital applications into physical environments.

By combining AI, robotics, automated laboratories and intelligent manufacturing, MegaRobo is working to transform how scientific experiments are conducted and how industries operate.

As investment in AI for Science continues to grow, MegaRobo could become an important contributor to the next generation of scientific and industrial innovation.

The future of AI may not simply be about machines that think. It could be about intelligent systems that experiment, observe, learn and help humanity discover what was once impossible.                                                                                                                                                                                                                                Written By                                                                                                                                                                                                        Usha  

Leave a Reply

Your email address will not be published. Required fields are marked *